Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.

Hodgkin lymphoma (formerly known as Hodgkin disease), which involves an abnormal type of lymphocyte called Reed-Sternberg cells Non-Hodgkin lymphoma, which does not contain Reed-Sternberg cells ...

Although there are many subtypes of lymphoma, skin lymphomas only make up about 4% of the total of all NHL. In rare cases, skin lymphomas can travel to the lymph nodes causing a painless lump around ...

Non-Hodgkin lymphoma is cancer involving the lymphatic system, which includes components of your immune system such as your lymph nodes and spleen. About one in 50 people—or 2 percent—will develop non ...

OAL consists of five types of lymphoma, the most common of which is extranodal marginal zone (EMZL) or mucosa-associated lymphoid tissue (MALT) type followed by the follicular lymphoma.

Mucosa-associated lymphoid tissue (MALT) lymphoma is rarely observed in the gallbladder, and its diagnosis before surgery is difficult. This report describes a case of primary MALT lymphoma of the ...

Calquence is under clinical development by AstraZeneca and currently in Phase II for Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma). According to ...

The protease mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1) is a signaling protein with both molecular scaffolding and protease activity involved in lymphocyte activation. MALT1 is ...

Non-Hodgkin lymphoma (NHL) is one of the most common cancers in the United States, accounting for about 4% of all cancers. The American Cancer Society’s estimates for non-Hodgkin lymphoma in 2025 are: ...